Two-thirds of 152 patients treated for high-grade cervical disease, free of persistence/recurrence, and followed-up both with human papillomavirus (HPV) DNA testing and HPV genotyping cleared their high-risk HPV infection within 1year. Viral clearance continued at diminishing rates during the second and the third year, at the end of which it was virtually complete.
Keywords: Cervical cancer; Cervical intraepithelial neoplasia; Follow-up; Genotyping; Human papillomavirus; Viral clearance.
Copyright © 2016 Elsevier Inc. All rights reserved.